Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0524702
Disease: Pulmonary Thromboembolisms
Pulmonary Thromboembolisms
0.310 Biomarker disease BEFREE The efficacy of reteplase against PTE in comparison to alteplase was clarified for the first time, and this PTE model could be further applied to studies of novel thrombolytic therapies. 30464403 2018
CUI: C0524702
Disease: Pulmonary Thromboembolisms
Pulmonary Thromboembolisms
0.310 Therapeutic disease CTD_human Heparin induced thrombocytopenia and re-thrombosis associated with warfarin and fondaparinux in a child. 19415734 2009
CUI: C0524702
Disease: Pulmonary Thromboembolisms
Pulmonary Thromboembolisms
0.310 Biomarker disease CTD_human Heparin induced thrombocytopenia and re-thrombosis associated with warfarin and fondaparinux in a child. 19415734 2009
CUI: C0524702
Disease: Pulmonary Thromboembolisms
Pulmonary Thromboembolisms
0.310 Biomarker disease CTD_human Fibrinogenolysis and thrombin generation after reduced dose bolus or conventional rt-PA for pulmonary embolism. The Coagulation Project Investigators of the Bolus Alteplase Pulmonary Embolism Group. 9199818 1997
CUI: C0524702
Disease: Pulmonary Thromboembolisms
Pulmonary Thromboembolisms
0.310 Therapeutic disease CTD_human Increasing age is a major risk factor for hemorrhagic complications after pulmonary embolism thrombolysis. 9266785 1997
CUI: C0524702
Disease: Pulmonary Thromboembolisms
Pulmonary Thromboembolisms
0.310 Biomarker disease CTD_human Increasing age is a major risk factor for hemorrhagic complications after pulmonary embolism thrombolysis. 9266785 1997
CUI: C0524702
Disease: Pulmonary Thromboembolisms
Pulmonary Thromboembolisms
0.310 Therapeutic disease CTD_human Fibrinogenolysis and thrombin generation after reduced dose bolus or conventional rt-PA for pulmonary embolism. The Coagulation Project Investigators of the Bolus Alteplase Pulmonary Embolism Group. 9199818 1997
CUI: C0524702
Disease: Pulmonary Thromboembolisms
Pulmonary Thromboembolisms
0.310 Therapeutic disease CTD_human Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomized trial. The Bolus Alteplase Pulmonary Embolism Group. 8082347 1994
CUI: C0524702
Disease: Pulmonary Thromboembolisms
Pulmonary Thromboembolisms
0.310 Biomarker disease CTD_human Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomized trial. The Bolus Alteplase Pulmonary Embolism Group. 8082347 1994
CUI: C0524702
Disease: Pulmonary Thromboembolisms
Pulmonary Thromboembolisms
0.310 Biomarker disease CTD_human [Dissolution of a right cardiac migrant thromboembolus in pulmonary embolism after treatment with rt-PA. Report of a successfully treated case]. 8451030 1993
CUI: C0524702
Disease: Pulmonary Thromboembolisms
Pulmonary Thromboembolisms
0.310 Therapeutic disease CTD_human [Dissolution of a right cardiac migrant thromboembolus in pulmonary embolism after treatment with rt-PA. Report of a successfully treated case]. 8451030 1993
CUI: C0524702
Disease: Pulmonary Thromboembolisms
Pulmonary Thromboembolisms
0.310 Biomarker disease CTD_human Effects of hydralazine and increased cardiac output on recombinant tissue plasminogen activator-induced thrombolysis in canine pulmonary embolism. 1899825 1991
CUI: C0524702
Disease: Pulmonary Thromboembolisms
Pulmonary Thromboembolisms
0.310 Therapeutic disease CTD_human Effects of hydralazine and increased cardiac output on recombinant tissue plasminogen activator-induced thrombolysis in canine pulmonary embolism. 1899825 1991
CUI: C0524702
Disease: Pulmonary Thromboembolisms
Pulmonary Thromboembolisms
0.310 Therapeutic disease CTD_human A new manifestation and treatment alternative for heparin-induced thrombosis. 2123154 1990
CUI: C0524702
Disease: Pulmonary Thromboembolisms
Pulmonary Thromboembolisms
0.310 Biomarker disease CTD_human A new manifestation and treatment alternative for heparin-induced thrombosis. 2123154 1990
CUI: C0524702
Disease: Pulmonary Thromboembolisms
Pulmonary Thromboembolisms
0.310 Therapeutic disease CTD_human Pulmonary perfusion after rt-PA therapy for acute embolism: early improvement assessed with segmental perfusion scanning. 3122266 1988
CUI: C0524702
Disease: Pulmonary Thromboembolisms
Pulmonary Thromboembolisms
0.310 Biomarker disease CTD_human Pulmonary perfusion after rt-PA therapy for acute embolism: early improvement assessed with segmental perfusion scanning. 3122266 1988
CUI: C0524702
Disease: Pulmonary Thromboembolisms
Pulmonary Thromboembolisms
0.310 Biomarker disease CTD_human Recombinant tissue plasminogen activator in patients with pulmonary embolism: correlation of fibrinolytic specificity and efficacy. 3105914 1987
CUI: C0524702
Disease: Pulmonary Thromboembolisms
Pulmonary Thromboembolisms
0.310 Therapeutic disease CTD_human Recombinant tissue plasminogen activator in patients with pulmonary embolism: correlation of fibrinolytic specificity and efficacy. 3105914 1987